Assignee
FLAMEL IRELAND LTD
IE·53 granted patents·26 pending applications·993 citations·filing 2013–2025
Top patents by PatentIndex Score
79 records- 0199US11839597B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Dec 12, 2023·27 cites·30 claims
- 0299US11065224B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Jul 20, 2021·42 cites·38 claims
- 0399US10973795B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Apr 13, 2021·48 cites·24 claims
- 0499US10952986B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Mar 23, 2021·50 cites·31 claims
- 0598US11052061B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Jul 6, 2021·33 cites·24 claims
- 0698US11000498B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted May 11, 2021·38 cites·20 claims
- 0798USRE47084EOral medicinal product with modified release of at least one active principle in multimicrocapsular formFLAMEL IRELAND LTD·Filed 2016·Granted Oct 16, 2018·36 cites·74 claims
- 0898US9814684B2Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)FLAMEL IRELAND LTD·Filed 2015·Granted Nov 14, 2017·36 cites·31 claims
- 0997US12128021B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Oct 29, 2024·12 cites·26 claims
- 1097US12097175B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Sep 24, 2024·9 cites·30 claims
- 1197US11986451B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted May 21, 2024·24 cites·26 claims
- 1297US11504347B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Nov 22, 2022·38 cites·25 claims
- 1397US10736866B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Aug 11, 2020·53 cites·52 claims
- 1497US10272062B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2017·Granted Apr 30, 2019·68 cites·89 claims
- 1596US12257223B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Mar 25, 2025·2 cites·14 claims
- 1696US12138239B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 12, 2024·9 cites·30 claims
- 1796US12115145B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·29 claims
- 1896US12115144B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·15 claims
- 1996US12115143B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·26 claims
- 2096US12115142B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·30 claims
- 2196US11896572B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Feb 13, 2024·28 cites·1 claims
- 2296US11826335B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 28, 2023·27 cites·10 claims
- 2396US11766418B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted Sep 26, 2023·27 cites·11 claims
- 2496US11602512B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Mar 14, 2023·36 cites·11 claims
- 2596US11602513B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Mar 14, 2023·36 cites·27 claims
- 2696US11583510B1Methods of administering gamma hydroxybutyrate formulations after a high-fat mealFLAMEL IRELAND LTD·Filed 2022·Granted Feb 21, 2023·37 cites·14 claims
- 2795US12226388B2Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Feb 18, 2025·2 cites·29 claims
- 2895US11779557B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted Oct 10, 2023·7 cites·6 claims
- 2995US11400065B2Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2020·Granted Aug 2, 2022·37 cites·110 claims
- 3095US10925844B2Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2020·Granted Feb 23, 2021·51 cites·29 claims
- 3195US10092511B2Controlled-release floating pharmaceutical compositionsFLAMEL IRELAND LTD·Filed 2016·Granted Oct 9, 2018·43 cites·23 claims
- 3294US12263150B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Apr 1, 2025·1 cites·19 claims
- 3394US12263151B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Apr 1, 2025·1 cites·15 claims
- 3494US12239625B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Mar 4, 2025·1 cites·15 claims
- 3594US12226389B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Feb 18, 2025·1 cites·14 claims
- 3694US12186298B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Jan 7, 2025·1 cites·26 claims
- 3794US12109186B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 8, 2024·1 cites·11 claims
- 3894US10543186B1Cysteine composition and injectionFLAMEL IRELAND LTD·Filed 2019·Granted Jan 28, 2020·20 cites·28 claims
- 3994US10493051B1Cysteine composition and injectionFLAMEL IRELAND LTD·Filed 2019·Granted Dec 3, 2019·22 cites·27 claims
- 4094USRE46686EPharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applicationsFLAMEL IRELAND LTD·Filed 2016·Granted Jan 30, 2018·36 cites·74 claims
- 4194US2026097010A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
- 4293US12186296B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Jan 7, 2025·2 cites·63 claims
- 4392US12167991B2Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2024·Granted Dec 17, 2024·1 cites·23 claims
- 4492US2026014111A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
- 4591US12303478B2Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2024·Granted May 20, 2025·1 cites·30 claims
- 4691US12167992B2Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2024·Granted Dec 17, 2024·1 cites·26 claims
- 4789US12144793B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 19, 2024·0 cites·23 claims
- 4889US12097176B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Sep 24, 2024·0 cites·6 claims
- 4989US2024366548A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Application pending·0 cites
- 5086US2026091013A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →